(1)
Love, R. By the Metrics Surgical Oophorectomy Plus Tamoxifen Is the First Adjuvant Treatment Option for Premenopausal Women With Hormone Receptor Positive Breast Cancer. Arch Breast Cancer 2021, 8-13.